E-ISSN: 2147-2688
Neck Dissection in Early-stage Squamous Cell Carcinoma of the Lower Lip: Mid-term Treatment Results
PDF
Cite
Share
Request
Original Article
VOLUME: 58 ISSUE: 4
P: 333-337
September 2020

Neck Dissection in Early-stage Squamous Cell Carcinoma of the Lower Lip: Mid-term Treatment Results

Med Bull Haseki 2020;58(4):333-337
DOI: 10.4274/haseki.galenos.2020.5956
Özlem Bayram
Reşit Murat Açıkalın
1. Sağlık Bilimleri Üniversitesi, Haseki Eğitim ve Araştırma Hastanesi, Kulak Burun Boğaz Kliniği, İstanbul, Türkiye
No information available.
No information available
Received Date: 09.02.2020
Accepted Date: 01.06.2020
Publish Date: 10.09.2020
PDF
Cite
Share
Request

ABSTRACT

Conclusion:

In early-stage SCC of the lower lip, a tumor size greater than 21.5 mm and depth of tumor invasion greater than 7 mm are associated with increased neck metastasis. Elective neck dissection should be performed in these high-risk patients.

Results:

Fifteen patients (38.5%) were identified as having pT1 and 24 patients (61.5%), pT2. The mean tumor size was 16.8 mm and the mean invasion depth was 6.3 mm. Neck dissection was performed in 22 (56.4%) patients (6/15 pT1 patients and 16/24 pT2 patients). Lymph node involvement was reported in two (9.09%) of 22 patients. Both patients had pT2 stage tumors. Recurrence was observed in one patient (patient with pT2 tumor). The 5-year survival rate was calculated as 82.05%.

Methods:

The study included 52 patients who were operated between 2010 and 2017 for early-stage primary SSC of the lip with negative surgical margins and without oral commissure involvement T1 and T2 without lymph node or distant metastasis. Patients with missing data or patients with a history of additional malignancy at the time of diagnosis were excluded from the study (n=13). The data of the remaining 39 patients were further analyzed.

Aim:

To evaluate the mid-term treatment results in early-stage squamous cell carcinoma (SCC) of the lower lip and to investigate the effect of tumor depth and size on neck metastasis.

References

1
Chi AC. Epithelial pathology-lip vermilion carcinoma. In: Neville BW, Damm DD, Allen CM, Bouquot JE, editors. Oral and Maxillofacial Pathology. 3rd ed. Philadelphia: Saunders; 2009. p. 414-5.
2
Zitsch RP 3rd. Carcinoma of the lip. Otolaryngol Clin North Am 1993;26:265-77.
3
Effiom OA, Adeyemo WL, Omitola OG, Ajayi OF, Emmanuel MM, Gbotolorun OM. Oral squamous cell carcinoma: a clinicopathologic review of 233 cases in Lagos, Nigeria. J Oral Mawillofac Sure 2008;66:1595-9.
4
Day TA, Davis BK, Gillespie MB. Oral cancer treatment. Curr Treat Options Oncol 2003;4:27-41.
5
Tanyeri G, Eskiizmir G. The management, current treatment modalities and reconstruction techniques for lip cancer. Turk Arch Otolaryngol 2014;52:22-32.
6
Bucur A, Stefanescu L. Management of patients with squamous cell carcinoma of the lower lip and N0-neck. J Craniomaxillofac Surg 2004;32:16-8.
7
Hasson O. Squamous cell carcinoma of the lower lip. J Oral Maxillofac Surg 2008;66:1259-62.
8
Vukadinovic M, Jezdic Z, Petrovic M, Medenica LM, Lens M. Surgical management of squamous cell carcinoma of the lip: analysis of a 10-year experience in 223 patients. J Oral Maxillofac Surg 2007;65:675-9.
9
Lydiatt WM, Patel SG, O’Sullivan B. Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67:122-37.
10
Bhandari K, Wang DC, Li SC, et al. Primary cN0 lip squamous cell carcinoma and elective neck dissection: systematic review and meta-analysis. Head Neck 2015;37:1392-400.
11
D’Cruz AK, Vaish R, Kapre N, et al. Elective versus therapeutic neck dissection in nodenegative oral cancer. N Engl J Med 2015;373:521-9.
12
Shah JP, Gil Z. Current concepts in management of oral cancer-surgery. Oral Oncol 2009;45:394-401.
13
Eskiizmir G, Ozgur E, Karaca G, Temiz P, Yanar NH, Ozyurt BC. Stage is a prognostic factor for surgically treated patients with early-stage lip cancer for whom a ‘wait and see ‘policy in terms of neck status has been implemented. J Laryngol Otol 2017;131:889-94.
14
Rena W, Lia Y, Liua C, et al. Surgical management of Squamous Cell Carcinoma of the lower lip: An experience of 109 cases. Med Oral Patol Oral Cir Bucal 2014;19: 398-5.
15
Bradley PJ, Ferlito A, Silver CE, et al. Neck treatment and shoulder morbidity: still a challenge. Head Neck 2011;33:1060-7.
16
Rodolico V, Barresi E, Di Lorenzo R, et al. Lymph node metastasis in lower lip squamous cell carcinoma in relation to tumour size, histologic variables and p27Kip1 protein expression. Oral Oncol 2004;40:92-8.
17
Ant A, Kilic C, Baltu Y, et al. Lip cancer: Reconsidering the at-risk patients with pathological assessment Oral Dis 2019;25:742-9.
18
International Consortium for Outcome Research (ICOR) in Head and Neck Cancer, Ebrahimi A, Gil Z. Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study. JAMA Otolaryngol Head Neck Surg 2014;140:1138-48.
19
Cooper JS, Porter K, Mallin K, et al. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 2009;31:748-58.